Hemoglobin and Ferritin Targets in CKD Patients
For adult CKD patients, maintain hemoglobin between 11-12 g/dL, transferrin saturation (TSAT) ≥20%, and serum ferritin ≥100 ng/mL, with an upper safety limit of ferritin at 500-800 ng/mL. 1
Hemoglobin Targets
The target hemoglobin range of 11-12 g/dL applies to all CKD patients regardless of dialysis status 1, 2. This recommendation prioritizes:
- Quality of life improvement through symptom relief
- Avoidance of transfusions and associated complications
- Safety concerns - hemoglobin should not exceed 13 g/dL 2
Critical caveat: The 2006-2007 KDOQI guidelines were revised after the CHOIR and CREATE trials demonstrated harm with higher hemoglobin targets (attempting normalization) 3, 2. Targeting hemoglobin >13 g/dL increases cardiovascular risk and mortality without additional benefit.
When hemoglobin temporarily rises above 12 g/dL during treatment, this is acceptable as long as the 3-month rolling average remains ≤12.5 g/dL 1. The rate of hemoglobin rise should not exceed 1 g/dL per 2-week period 2.
Iron Parameters: The Dual Target Approach
Minimum Thresholds (Treat if Below)
- TSAT ≥20% 1
- Ferritin ≥100 ng/mL for non-dialysis and peritoneal dialysis patients 1
- Ferritin ≥200 ng/mL for hemodialysis patients (per more recent evidence) 4
Upper Safety Limits (Withhold Iron if Exceeded)
The rationale: These thresholds distinguish between absolute iron deficiency (depleted stores) and functional iron deficiency (adequate stores but insufficient availability for erythropoiesis stimulated by ESAs) 1. The KDIGO 2012 guideline set the upper ferritin limit at 500 µg/L for hemodialysis patients 5, though the older KDOQI guidelines used 800 ng/mL as the threshold to withhold IV iron 1.
Monitoring Schedule
During ESA initiation or dose escalation:
- Check TSAT and ferritin monthly if NOT receiving IV iron 1
- Check every 3 months if receiving IV iron 1
After achieving target hemoglobin:
- Monitor TSAT and ferritin at least every 3 months 1
Important timing consideration: If large IV iron doses (≥1000 mg) are given, wait 2 weeks before measuring iron parameters for accuracy 1. For doses of 100-125 mg weekly or less, no interruption is needed 1.
Iron Supplementation Strategy
Hemodialysis Patients
Most hemodialysis patients require regular IV iron to maintain targets 1. Oral iron is insufficient due to high dialyzer blood losses 1.
Initial repletion (if TSAT <20% or ferritin <100 ng/mL):
- Give 100-125 mg IV iron per dialysis session for 8-10 doses 1
- Repeat course if targets not achieved 1
Maintenance (once targets achieved):
Withhold IV iron if TSAT >50% or ferritin >800 ng/mL for up to 3 months, then recheck parameters 1. When resuming, reduce dose by one-third to one-half 1.
Non-Dialysis and Peritoneal Dialysis Patients
Either oral or IV iron is acceptable 4. If oral iron is used, give at least 200 mg elemental iron daily for adults 1. However, many patients cannot maintain adequate iron status with oral iron alone 1.
Functional Iron Deficiency Recognition
Even with TSAT ≥20% and ferritin ≥100 ng/mL, some patients remain functionally iron deficient, particularly those requiring high ESA doses 1.
Trial of IV iron is warranted when:
- Hemoglobin <11 g/dL despite adequate iron parameters 1
- High ESA doses needed to maintain hemoglobin 11-12 g/dL 1
Give 1.0 g IV iron over 8-10 weeks and observe response 1. If hemoglobin increases or ESA dose can be reduced while maintaining hemoglobin, continue iron supplementation 1. If no response after two courses, reduce to maintenance dosing 1.
Common Pitfalls
Distinguishing functional iron deficiency from inflammatory block: Both can present with TSAT <20% and ferritin 100-700 ng/mL 1. In functional deficiency, ferritin gradually decreases during ESA therapy but remains >100 ng/mL. In inflammatory block, ferritin abruptly increases with sudden TSAT drop 1. Give weekly IV iron (50-125 mg) for 8-10 doses; if no erythropoietic response occurs, inflammatory block is likely 1.
Ferritin as acute phase reactant: Ferritin rises with infection or inflammation independent of iron stores 1. This can mask true iron deficiency or falsely suggest iron overload.
Avoiding iron overload: The evidence shows patients are unlikely to benefit from further iron supplementation once TSAT exceeds 50% or ferritin exceeds 800 ng/mL 1. The 2016 review raised concerns about excessive IV iron use, noting median ferritin levels rose to 650 µg/L in US dialysis patients, with 34% exceeding 800 µg/L 5.